Cannabis for nausea: chemo, antiemetic & studies
- Dronabinol FDA-approved for chemotherapy nausea since 1985 – one of the oldest cannabis indications
- CB1 in the area postrema (vomiting center) directly inhibits the serotonergic nausea signaling cascade
- THC + ondansetron (5-HT3 antagonist) = significantly better than ondansetron alone (Meiri 2007)
Cannabis as an antiemetic: an established field of application
Nausea and vomiting during chemotherapy (Chemotherapy-Induced Nausea and Vomiting, CINV) are the most distressing side effects for many cancer patients. Cannabis has the best medical evidence in this area and was historically the first cannabinoid to be used clinically: dronabinol (synthetic THC) received FDA approval for CINV in the USA in 1985.
Neurobiological mechanisms
The vomiting center (area postrema) and the nucleus tractus solitarius in the brain stem express CB1 receptors. THC activates these receptors and thus inhibits the serotonergic and dopaminergic nausea signaling cascade:
THC mechanism:
– CB1 activation in the area postrema → inhibits substance P and 5-HT3 release → attenuation of nausea
– Dopaminergic system (D2 receptors): THC inhibits dopamine release → antiemetic (similar to classic antiemetics such as metoclopramide)
– Appetite stimulation via hypothalamus (CB1) → Counterbalance to chemotherapy-induced anorexia
CBD mechanism:
– 5-HT1A agonism: reduces nausea via serotonin modulation (similar to ondansetron)
– FAAH inhibition: increases anandamide → additional antiemetic component
– Anxiolysis: Anticipatory nausea (Pavlov-conditioned nausea before chemo) can be reduced by CBD anxiety reduction
Study situation: Cannabis against CINV
| Study | Design | Result |
|---|---|---|
| Meiri et al. 2007 (Oncology) | RCT, n=64 chemo patients, THC:CBD capsule vs. placebo vs. prochlorperazine | THC:CBD more effective than prochlorperazine in CINV; 73 % responders in cannabinoid group |
| Nabilone meta-analysis, Machado Rocha 2008 (Eur J Cancer Care) | 30 RCTs, n=1,366, cannabinoids vs. classic antiemetics | Cannabinoids more effective than prochlorperazine, metoclopramide, haloperidol; worse than ondansetron for acute nausea |
| Strasser et al. 2006 (Lancet Oncol) | RCT, n=243 cancer patients, cannabis extract vs. THC vs. placebo | No difference to placebo in appetite; but nausea responder rate tended to be better in cannabinoid groups |
| Duran et al. 2010 (J Pain Symptom Manage) | RCT, n=16, Sativex (THC:CBD 1:1) for CINV-refractory vomiting | Significant reduction in vomiting and nausea; well tolerated |
Approved preparations
Dronabinol (Marinol, Syndros): Synthetic THC. Available in Germany as dronabinol capsules or drops on a BtM prescription. Indication: CINV and HIV anorexia. Advantage: Standardized dosage. Disadvantage: No entourage effect (no CBD, no terpenes).
Nabilone (Cesamet): Synthetic THC analog. Stronger than dronabinol. Also BtM prescription. Frequently used in the UK and Canada, rarely available in Germany.
Sativex (nabiximols): THC:CBD 1:1 oromucosal spray. Approved in Germany as a combination preparation for MS spasticity; CINV off-label.
Flowers/oils on cannabis prescription: full-spectrum products with THC and CBD. Flexible dosage, entourage effect possible. GKV reimbursement possible for CINV indication.
Cannabis for anticipatory nausea
Up to 25 % of chemo patients develop anticipatory nausea – nausea before chemo due to conditioning (sight of the clinic, smells). Ondansetron and classic antiemetics often fail here. CBD with its anxiolysis can dampen anticipatory nausea, as anxiety is the main trigger.
Cannabis in palliative care - Cannabis for Crohn’s disease
FAQ: Cannabis for nausea
Summary
Cannabis for chemotherapy nausea is the best documented medical cannabinoid use. Dronabinol has been approved since 1985; meta-analyses show superiority over older antiemetics. THC acts via CB1 in the vomiting center, CBD via 5-HT1A and anxiolysis in anticipatory nausea. Cannabis is often the last effective option for refractory CINV. Applying for cannabis on prescription explains the SHI reimbursement pathway; also relevant for cancer patients: Cannabis for tumor pain.














